Tomoya Onodera
Overview
Explore the profile of Tomoya Onodera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hanazawa K, Shiomi H, Morimoto T, Ando K, Furukawa Y, Tada T, et al.
Circ J
. 2025 Jan;
89(3):364-372.
PMID: 39864826
Background: Fatal arrhythmic events (FAEs), such as sudden cardiac death (SCD) and fatal ventricular arrhythmias, are a devastating complication in patients with coronary artery disease (CAD). Therefore, in this study...
2.
Aihara K, Torii S, Nakamura N, Hozumi H, Shiozaki M, Sato Y, et al.
Am Heart J
. 2024 Aug;
277:114-124.
PMID: 39121917
Background: The optimal duration of dual antiplatelet therapy after currently available drug-eluting stent (DES) implantation to prevent stent thrombosis (ST) remains controversial. Delayed healing is frequently identified as a leading...
3.
Kanenawa K, Yamaji K, Morimoto T, Yamamoto K, Domei T, Hyodo M, et al.
J Cardiol
. 2024 Jun;
84(4):300-310.
PMID: 38871119
Background: The impact of very low baseline levels of low-density lipoprotein cholesterol (LDL-C) on patients with coronary artery disease remains unclear. Method: We enrolled 39,439 patients of the pooled population...
4.
Yamamoto K, Morimoto T, Natsuaki M, Shiomi H, Ozasa N, Sakamoto H, et al.
Circ J
. 2023 Sep;
88(6):888-899.
PMID: 37722886
Background: Polypharmacy was reported to be associated with major bleeding in various populations. However, there are no data on polypharmacy and its association with bleeding in patients undergoing percutaneous coronary...
5.
Yamashita S, Sakamoto A, Shoji S, Kawaguchi Y, Wakabayashi Y, Matsunaga M, et al.
J Cardiovasc Dev Dis
. 2023 May;
10(5).
PMID: 37233171
Background: The guideline-recommended low-density lipoprotein cholesterol target level of <70 mg/dL may not be achieved with statin administration in some patients with acute coronary syndrome (ACS). Therefore, the proprotein convertase...
6.
Yamaji K, Shiomi H, Morimoto T, Matsumura-Nakano Y, Ehara N, Sakamoto H, et al.
JACC Asia
. 2022 Nov;
2(3):294-308.
PMID: 36411876
Background: Diabetes is a well-known risk factor for adverse outcomes after coronary revascularization. Objectives: This study sought to determine high-risk subgroups in whom the excess risks of diabetes relative to...
7.
Takeji Y, Morimoto T, Shiomi H, Toda Kato E, Imada K, Yoshikawa Y, et al.
Circ J
. 2022 Nov;
87(2):277-286.
PMID: 36351607
Background: There is a scarcity of studies comparing the clinical outcomes after percutaneous coronary intervention (PCI) for women and men stratified by the presentation of acute coronary syndromes (ACS) or...
8.
Yoshikawa Y, Shiomi H, Morimoto T, Takeji Y, Matsumura-Nakano Y, Yamamoto K, et al.
JACC Asia
. 2022 Nov;
1(3):345-356.
PMID: 36341224
Background: There are limited data on the long-term stent-related adverse events as related to the duration of dual antiplatelet therapy (DAPT) in second-generation (G2) drug-eluting stents (DES) compared with first-generation...
9.
Watanabe H, Yamamoto K, Shiomi H, Morimoto T, Kato E, Matsumura Y, et al.
PLoS One
. 2022 Sep;
17(9):e0267906.
PMID: 36174029
Aims: There is a scarcity of studies comparing percutaneous coronary intervention (PCI) using new-generation drug-eluting stents (DES) with coronary artery bypass grafting (CABG) in patients with multi-vessel coronary artery disease....
10.
Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Takeji Y, Yamaji K, et al.
Am J Cardiol
. 2021 Dec;
164:34-43.
PMID: 34852931
Recently, one observational study showed that patients with ST-segment elevation myocardial infarction (STEMI) without standard cardiovascular risk factors were associated with increased mortality compared with patients with risk factors. This...